La dosis recomendada suele oscilar entre 500 mg y 3000 mg al da, dependiendo de las necesidades individuales
Results of Treatment for patients with Acute Myelogenous Leukemia (AML) who are ineligible for protocols
Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I
However, these drug-linked interruptions in food noise wore off after a few months, suggesting that tirzepatide is not a permanent solution to conditions such as binge eating
It is also important to note that most of these studies focus on short-term effects that may not hold up with extended use
Combination with Complementary Peptides: Some protocols combine AOD-9604 with other metabolic or body composition peptides for synergistic effects